PMID: 8971023Dec 1, 1996Paper

Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy

Journal of Virology
G P GaoJ M Wilson

Abstract

Recombinant adenoviruses with E1 sequences deleted efficiently transfer genes into a wide variety of target cells. Antigen- and nonantigen-specific responses to the therapy lead to toxicity, loss of transgene expression, and difficulties with vector readministration. We have created new cell lines that allowed the isolation of more disabled adenovirus vectors that have both E1 and E4 deletions. Studies with murine models of liver-directed gene therapy indicated that the E1- and E4-deleted vector expresses fewer virus proteins and induces less apoptosis, leading to blunted host responses and an improved safety profile. The impact of the E4 deletion on the stability of vector expression was confounded by immune responses to the transgene product, which in this study was beta-galactosidase. When transgene responses were eliminated, the doubly deleted vector was substantially more stable in mouse liver than was the E1-deleted construct. These studies indicate that adenovirus vectors with both E1 and E4 deletions may have advantages in terms of safety and efficacy over first-generation constructs for liver-directed gene therapy.

References

Aug 1, 1992·Nature Genetics·H A JaffeM Perricaudet
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S D NeillJ R Nevins
Feb 1, 1989·Journal of Virology·E Bridge, G Ketner
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·D H Weinberg, G Ketner
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·M A KayA R Thompson
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y YangJ M Wilson
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J Herz, R D Gerard
Jan 20, 1996·Human Gene Therapy·S ConnellyM Kaleko

❮ Previous
Next ❯

Citations

Aug 1, 1998·Journal of Inherited Metabolic Disease·S E RaperM L Batshaw
Feb 5, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M OzakiK Irani
Dec 21, 2000·Current Atherosclerosis Reports·D J Rader, U J Tietge
Jul 28, 2001·Clinical and Experimental Pharmacology & Physiology·R G PanchalS Petrou
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Mary Jayne Kennedy
Feb 11, 2005·Human Gene Therapy·Donna J Palmer, Philip Ng
Jun 20, 2007·Journal of Cellular Physiology·Terence R Flotte
Jun 27, 2009·Expert Reviews in Molecular Medicine·Lindsey A Muir, Jeffrey S Chamberlain
Aug 1, 2010·Viruses·Imre Kovesdi, Susan J Hedley
Jan 1, 2011·Pharmaceutics·Mitsuhiro MachitaniHiroyuki Mizuguchi
Apr 24, 2014·Human Gene Therapy·James M Wilson
Mar 5, 1998·Circulation Research·S Baek, K L March
Sep 12, 2000·Current Cardiology Reports·J F DedieuD Branellec
Aug 18, 1999·Proceedings of the National Academy of Sciences of the United States of America·J BennettS G Jacobson
Jan 17, 2002·Acta Microbiologica Et Immunologica Hungarica·I Nász, E Adám
Feb 19, 2000·Microscopy Research and Technique·D Hartigan-O'Connor, J S Chamberlain
Aug 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·Guang-Ping GaoJames M Wilson
Oct 3, 2001·Journal of Virology·W ZhangM J Imperiale
May 11, 2000·Japanese Journal of Cancer Research : Gann·A NatsumeJ Yoshida
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·B LeeA L Beaudet

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis